Linc AB (STO: LINC)

Market Cap	4.40B
Revenue (ttm)	1.57B
Net Income (ttm)	1.58B
Shares Out	57.91M
EPS (ttm)	27.30
PE Ratio	2.78
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	28,710
Open	75.90
Previous Close	75.90
Day's Range	74.30 - 76.90
52-Week Range	52.20 - 103.40
Beta	0.97
Analysts	n/a
Price Target	n/a
Earnings Date	Jan 24, 2025

About Linc AB

Linc AB is a private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies. It prefers to invest in drug development usually take place at an early stage, while investments in medical technology are made in more mature businesses. The investments are made in both private and public companies and in research and operational companies. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million ($2.99 million) and SEK 250 million ($29.9...

• Industry: Asset Management
• Sector: Financials
• Founded: 1991
• Employees: 2
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: LINC